BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25548568)

  • 1. Aromatic Amines Exert Contrasting Effects on the Anticoagulant Effect of Acetaldehyde upon APTT.
    Hall L; Murrey SJ; Brecher AS
    Adv Hematol; 2014; 2014():735751. PubMed ID: 25548568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of glycosaminoglycans with acetaldehyde on the activation of prothrombin.
    Brecher AS; Adamu MT
    Can J Physiol Pharmacol; 2005 May; 83(5):431-8. PubMed ID: 15897925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of biogenic amine hormones with acetaldehyde.
    Murrey SJ; Brecher AS
    Dig Dis Sci; 2010 Jan; 55(1):21-7. PubMed ID: 19241168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyamines detoxify the anticoagulant effect of acetaldehyde on prothrombin time.
    Brecher AS; Riaz AH
    J Cardiovasc Pharmacol; 2012 Jul; 60(1):1-7. PubMed ID: 22407337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.
    Johnstone IB; Martin CA
    Can J Vet Res; 2000 Apr; 64(2):117-22. PubMed ID: 10805251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of B-complex vitamins upon the prolongation of prothrombin time by acetaldehyde.
    Catazaro JR; Brecher AS
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):477-83. PubMed ID: 23406661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients.
    Atallah S; Liebl M; Fitousis K; Bostan F; Masud F
    Perfusion; 2014 Sep; 29(5):456-61. PubMed ID: 24570077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of acetaldehyde-glycosaminoglycan mixtures upon Factor IXa and Factor IX-Deficient Plasma.
    Brecher AS; Moon AR; Gray KD
    Alcohol; 2006 Jun; 39(2):97-104. PubMed ID: 17134662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drotrecogin alfa activated (recombinant human activated protein C) in combination with heparin or melagatran: effects on prothrombin time and activated partial thromboplastin time.
    Koestenberger M; Cvirn G; Gallistl S; Muntean W
    Blood Coagul Fibrinolysis; 2004 Oct; 15(8):693-7. PubMed ID: 15613925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of acetaldehyde and glycosaminoglycans upon factor Xa- and factor X-deficient plasma.
    Brecher AS; Hommema EL
    Can J Physiol Pharmacol; 2002 Sep; 80(9):879-86. PubMed ID: 12430983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-blood clotting time, activated partial thromboplastin time, and whole-blood recalcification time as heparin monitoring tests.
    Ts'ao CH; Galluzzo TS; Lo R; Peterson KG
    Am J Clin Pathol; 1979 Jan; 71(1):17-21. PubMed ID: 420167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term effects of acetaldehyde on plasma.
    Brecher AS; Adamu MT
    Alcohol; 2002 Jan; 26(1):49-53. PubMed ID: 11958947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of deranged activated partial thromboplastin time for anaesthesia and surgery.
    Loizou E; Mayhew DJ; Martlew V; Murthy BVS
    Anaesthesia; 2018 Dec; 73(12):1557-1563. PubMed ID: 30315725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus Anticoagulant Testing: Activated Partial Thromboplastin Time (APTT) and Silica Clotting Time (SCT).
    Tripodi A; Chantarangkul V
    Methods Mol Biol; 2017; 1646():177-183. PubMed ID: 28804829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated partial thromboplastin time-protamine dose relation in the presence and absence of heparin.
    Inagaki M; Goto K; Katayama H; Benson KT; Goto H; Arakawa K
    J Cardiothorac Anesth; 1989 Dec; 3(6):734-6. PubMed ID: 2521031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Antiphospholipid Antibodies Effects on Activated Partial Thromboplastin Time Assays.
    Yao K; Zhang L; Zhou H; Tang N; Li D
    Am J Med Sci; 2017 Jul; 354(1):22-26. PubMed ID: 28755727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of prothrombin time and activated partial thromboplastin time in citrated whole blood samples from clinically ill dogs following storage.
    Maunder CL; Costa M; Cue SM; Crawford EM; Papasouliotis K; Murphy KF
    J Small Anim Pract; 2012 Sep; 53(9):531-5. PubMed ID: 22860986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous Magnesium Chloride Reduces the Activated Partial Thromboplastin Times of Lupus Anticoagulant-Positive Patients.
    Tokutake T; Baba H; Shimada Y; Takeda W; Sato K; Hiroshima Y; Kirihara T; Shimizu I; Nakazawa H; Kobayashi H; Ishida F
    PLoS One; 2016; 11(6):e0157835. PubMed ID: 27355205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longer aPTT values in healthy children than in adults: no single cause.
    Gallistl S; Muntean W; Leschnik B; Meyers W
    Thromb Res; 1997 Nov; 88(4):355-9. PubMed ID: 9526958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
    Brecher AS; Hellman K; Basista MH
    Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.